Howard Hughes Medical Institute’s Lennox International LII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-6
Closed -$2.91K – 292
2025
Q4
$2.91K Hold
6
– – ﹤0.01% 432
2025
Q3
$3.18K Hold
6
– – ﹤0.01% 421
2025
Q2
$3.44K Buy
+6
New +$3.35K ﹤0.01% 397

Other funds holding LII

Howard Hughes Medical Institute's LII Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Lennox International (LII) in Q1 2026, closing a stake of 6 shares — an estimated $2.91K sold.

Howard Hughes Medical Institute first reported a position in LII in Q2 2025 and held it in 3 quarters. The position peaked at $3.44K in Q2 2025. 630 funds tracked by Wall St. Rank hold LII as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Lennox International position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 6 Lennox International shares in Q1 2026, an estimated $2.91K.
  • Howard Hughes Medical Institute first reported a position in Lennox International in Q2 2025 and held it in 3 quarters.
  • Howard Hughes Medical Institute's Lennox International position peaked at $3.44K in Q2 2025.
  • 630 funds tracked by Wall St. Rank held Lennox International as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.